Q10 and Tekturna drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Q10 (coenzyme q - 10) and Tekturna (aliskiren hemifumarate). Common drug interactions include stress among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Q10 and Tekturna. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Q10?

Q10 has active ingredients of coenzyme q - 10. eHealthMe is studying from 34,261 Q10 users. Check the latest studies of Q10.

What is Tekturna?

Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. eHealthMe is studying from 4,730 Tekturna users. Check the latest studies of Tekturna.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

70 people who take Q10 and Tekturna together, and have interactions are studied.

What are the common drug interactions of Q10 and Tekturna, by gender? *:

female:

Stress
Therapeutic response decreased (less preventive response)
Weight decreased
Nephropathy (damage to or disease of a kidney)
Abdominal discomfort
Abdominal distension
Abscess (pus)
Ageusia (loss of taste functions of the tongue)
Arterial disorder
Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)

male:

Chronic kidney disease
Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
Bone density decreased
Flushing (the warm, red condition of human skin)
Haemorrhagic anaemia (anaemia due to excessive bleeding)
Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
Abdominal discomfort
Drug ineffective
Insomnia (sleeplessness)
Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Q10 and Tekturna, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone pain
Drug resistance (reduction in effectiveness of a drug)
Emotional distress
Gait disturbance
Pain
Renal impairment (severely reduced kidney function)

50-59:

Loss of consciousness
Lupus encephalitis (a chronic inflammatory autoimmune disorder that may affect brain)
Nausea (feeling of having an urge to vomit)
Partial seizures (seizures which affect only a part of the brain at onset)
Upper respiratory tract infection
Chronic kidney disease
Renal failure (kidney dysfunction)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Sinusitis (inflammation of sinus)

60+:

Dizziness
Flushing (the warm, red condition of human skin)
Chest pain
Urinary tract infection
Adverse drug reaction
Bowel movement irregularity
Cardiac valve disease (heart valve disease)
Cold sweat
Diarrhoea haemorrhagic (bloody diarrhoea)
Dysstasia (difficulty in standing)

What are the existing conditions these people have? *

High Blood Cholesterol: 14 people, 20.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 17.14%
Pain: 6 people, 8.57%
Blood Pressure Abnormal: 6 people, 8.57%
High Density Lipoprotein Decreased: 5 people, 7.14%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 5.71%
Diabetes: 4 people, 5.71%
Cardiac Disorder: 4 people, 5.71%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 5.71%
Asthma: 4 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Q10 and Tekturna?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously